[Read the rest of this article...]

Trimel announces that the FDA has approved its Investigational New Drug Application (IND) for TBS-7, an innovative approach to providing asthma sufferers with quick relief from their symptoms

[Read the rest of this article...]

[Read the rest of this article...]

[Read the rest of this article...]

[Read the rest of this article...]

[Read the rest of this article...]

• 25,000 square foot GMP-capable facility
• Clinical supplies to be manufactured in-house H2/2010.

[Read the rest of this article...]

• Award-winning nasal and pulmonary delivery platforms
• First Phase 3 study slated to begin in H2/2010

[Read the rest of this article...]

• Consequent to this successful Capital raising, the company has a knowledgeable high net worth shareholder base
• Issued Capital in excess of $100 Million

[Read the rest of this article...]

• Confirmatory multi-centre trial in the US conducted in hypogonadal males

[Read the rest of this article...]